Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

August 12, 2022

Study Completion Date

August 12, 2022

Conditions
Crohn Disease
Interventions
DEVICE

Vagal Nerve Stimulator

A handheld device which consists of a battery powered portable stimulator with a digital control user interface that controls signal amplitude and two steel contact electrodes will deliver the nVNS electrical stimulation to the cervical Vagus nerve. The device has been approved by the U.S. Food and Drug Administration (FDA) for non-invasive Vagus nerve stimulator therapy for adjunctive use for the prevention and treatment of migraine and cluster headaches in adult patients.

Trial Locations (1)

46202

Indiana University, Indianapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ElectroCore INC

INDUSTRY

lead

Indiana University

OTHER

NCT05165108 - Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study | Biotech Hunter | Biotech Hunter